| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:XR9051
CAS:762219-35-2
Package:100mg/RMB 21500;25mg/RMB 12800;50mg/RMB 16800
|
XR9051 manufacturers
- XR9051
-
- $3100.00 / 100mg
-
2024-10-28
- CAS:762219-35-2
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| Product Name: | XR9051 | | Synonyms: | XR9051;3-[(Z)-[(5Z)-5-benzylidene-4-methyl-3,6-dioxopiperazin-2-ylidene]methyl]-N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]benzamide;Benzamide, N-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-3-[(Z)-[(5Z)-4-methyl-3,6-dioxo-5-(phenylmethylene)-2-piperazinylidene]methyl]- | | CAS: | 762219-35-2 | | MF: | C39H38N4O5 | | MW: | 642.74 | | EINECS: | | | Product Categories: | | | Mol File: | 762219-35-2.mol |  |
| | XR9051 Chemical Properties |
| Boiling point | 836.2±65.0 °C(Predicted) | | density | 1.272±0.06 g/cm3(Predicted) | | pka | 11.57±0.20(Predicted) |
| | XR9051 Usage And Synthesis |
| Description | XR9051 is as a potent modulator of P-glycoprotein (P-gp)-mediated multidrug resistance (MDR) following a synthetic chemistry programme based on a natural product lead compound. XR9051 was shown to be a potent inhibitor of the binding of the cytotoxic to P-glycoprotein (EC50 = 1.4 +/- 0.5 nM). XR9051 reverses the MDR phenotype through direct interaction with P-glycoprotein. |
| | XR9051 Preparation Products And Raw materials |
|